Thursday, 13 February, 2025

Latent Labs Secures $50M to Revolutionize Drug Discovery with AI

Founded by former DeepMind scientist Simon Kohl, Latent Labs has raised $50 million to develop AI-driven synthetic proteins for drug discovery. The company aims to make biology "programmable" by leveraging generative AI to streamline the drug development process. Unlike traditional models, Latent Labs will serve as a service provider, collaborating with pharmaceutical companies to utilize its AI platform.